Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 151

    2.

    Are all aromatase inhibitors the same? A review of controlled clinical trials in breast cancer.

    Berry J.

    Clin Ther. 2005 Nov;27(11):1671-84. Review.PMID: 16368441 [PubMed - indexed for MEDLINE]Related articles

    3.

    Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial.

    Jakesz R, Jonat W, Gnant M, Mittlboeck M, Greil R, Tausch C, Hilfrich J, Kwasny W, Menzel C, Samonigg H, Seifert M, Gademann G, Kaufmann M, Wolfgang J; ABCSG and the GABG.

    Lancet. 2005 Aug 6-12;366(9484):455-62.PMID: 16084253 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: a meta-analysis.

    Jonat W, Gnant M, Boccardo F, Kaufmann M, Rubagotti A, Zuna I, Greenwood M, Jakesz R.

    Lancet Oncol. 2006 Dec;7(12):991-6. Erratum in: Lancet Oncol. 2007 Jan;8(1):6. PMID: 17138220 [PubMed - indexed for MEDLINE]Related articles

    5.

    Cardiovascular safety profiles of aromatase inhibitors : a comparative review.

    Nabholtz JM, Gligorov J.

    Drug Saf. 2006;29(9):785-801. Review. Erratum in: Drug Saf. 2007;30(3):201. PMID: 16944964 [PubMed - indexed for MEDLINE]Related articles

    6.

    Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.

    Jahanzeb M.

    Clin Ther. 2007 Aug;29(8):1535-47. Review.PMID: 17919537 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial.

    Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists' Group, Forbes JF, Cuzick J, Buzdar A, Howell A, Tobias JS, Baum M.

    Lancet Oncol. 2008 Jan;9(1):45-53.PMID: 18083636 [PubMed - indexed for MEDLINE]Related articles

    8.

    Anastrozole is cost-effective vs tamoxifen as initial adjuvant therapy in early breast cancer: Canadian perspectives on the ATAC completed-treatment analysis.

    Rocchi A, Verma S.

    Support Care Cancer. 2006 Sep;14(9):917-27. Epub 2006 Apr 5.PMID: 16596419 [PubMed - indexed for MEDLINE]Related articles

    9.

    Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.

    Jakesz R, Greil R, Gnant M, Schmid M, Kwasny W, Kubista E, Mlineritsch B, Tausch C, Stierer M, Hofbauer F, Renner K, Dadak C, Rücklinger E, Samonigg H; Austrian Breast and Colorectal Cancer Study Group.

    J Natl Cancer Inst. 2007 Dec 19;99(24):1845-53. Epub 2007 Dec 11. Erratum in: J Natl Cancer Inst. 2008 Feb 6;100(3):226. PMID: 18073378 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer.

    Buzdar A, Chlebowski R, Cuzick J, Duffy S, Forbes J, Jonat W, Ravdin P.

    Curr Med Res Opin. 2006 Aug;22(8):1575-85. Review.PMID: 16870082 [PubMed - indexed for MEDLINE]Related articles

    12.

    Improved overall survival in postmenopausal women with early breast cancer after anastrozole initiated after treatment with tamoxifen compared with continued tamoxifen: the ARNO 95 Study.

    Kaufmann M, Jonat W, Hilfrich J, Eidtmann H, Gademann G, Zuna I, von Minckwitz G.

    J Clin Oncol. 2007 Jul 1;25(19):2664-70. Epub 2007 Jun 11.PMID: 17563395 [PubMed - indexed for MEDLINE]Related articles

    13.

    The use of aromatase inhibitors in adjuvant therapy for early breast cancer.

    Jonat W, Hilpert F, Maass N.

    Cancer Chemother Pharmacol. 2005 Nov;56 Suppl 1:32-8. Review.PMID: 16273366 [PubMed - indexed for MEDLINE]Related articles

    14.

    Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: a systematic review.

    Eisen A, Trudeau M, Shelley W, Messersmith H, Pritchard KI.

    Cancer Treat Rev. 2008 Apr;34(2):157-74. Epub 2007 Dec 31. Review.PMID: 18164821 [PubMed - indexed for MEDLINE]Related articles

    15.

    Initial versus sequential adjuvant aromatase inhibitor therapy: a review of the current data.

    Ellis MJ, Rigden CE.

    Curr Med Res Opin. 2006 Dec;22(12):2479-87. Review.PMID: 17257462 [PubMed - indexed for MEDLINE]Related articles

    16.

    Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis.

    Sestak I, Cuzick J, Sapunar F, Eastell R, Forbes JF, Bianco AR, Buzdar AU; ATAC Trialists' Group.

    Lancet Oncol. 2008 Sep;9(9):866-72. Epub 2008 Aug 12.PMID: 18703382 [PubMed - indexed for MEDLINE]Related articles

    17.

    Treatment strategies that effectively reduce early recurrence risk in postmenopausal women with endocrine-sensitive breast cancer: AIs upfront vs. switching.

    Paepke S, Jacobs VR, Ohlinger R, Warm M, Kümmel S, Thomas A, Harbeck N, Kiechle-Bahat M.

    J Cancer Res Clin Oncol. 2007 Dec;133(12):905-16. Epub 2007 Sep 6. Review.PMID: 17805570 [PubMed - indexed for MEDLINE]Related articles

    18.

    Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis.

    Punglia RS, Burstein HJ, Winer EP, Weeks JC.

    J Natl Cancer Inst. 2008 May 7;100(9):642-8. Epub 2008 Apr 29.PMID: 18445827 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Cost-effectiveness of anastrozole compared to tamoxifen in hormone receptor-positive early breast cancer. Analysis based on the ATAC trial.

    Moeremans K, Annemans L.

    Int J Gynecol Cancer. 2006;16 Suppl 2:576-8.PMID: 17010076 [PubMed - indexed for MEDLINE]Related articles

    20.

    Adjuvant hormonal therapy for stage I endometrial cancer.

    Gien L, Kwon J, Oliver TK, Fung-Kee-Fung M.

    Curr Oncol. 2008 Jun;15(3):126-35.PMID: 18596890 [PubMed - in process]Related articlesFree article

    Supplemental Content

    Find related data